BioAlg Corp. logo — AI & ML in Cancer Biology

BioAlg Corp.

AI & ML in Cancer Biology

Founded 2017 United States Walnut, United States 1 employees Biotechnology, Pharmaceutical +1

General Information

Company Name BioAlg Corp.
Founded Year 2017
Location United States Walnut, United States
Employees 1
Industries Biotechnology, Pharmaceutical, SaaS
Social

BounceWatch is an independent company data service, not affiliated with BioAlg Corp.. To contact BioAlg Corp., visit bioalg.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About BioAlg Corp.

BioAlg Corp. is a biotechnology, pharmaceutical, and SaaS startup headquartered in the United States. Founded in 2017, the company's mission revolves around machine learning and computational biology to advance cancer treatment and drug design. Leveraging AI and ML in cancer biology, they aim to revolutionize the healthcare industry with innovative solutions. Although details about the last investment and its investors are currently unavailable, BioAlg Corp. holds significant promise in disrupting the intersection of technology and healthcare. With its compelling focus on addressing critical medical needs, the startup is poised to attract substantial attention from venture capital firms and investors seeking impactful opportunities in the biotech and pharmaceutical sectors. As the company continues to make strides in its innovative endeavors, it presents an intriguing prospect for investment due to its potential to spearhead transformative changes in cancer research and treatment.

Taxonomy: AI-driven platform, clinical trials simulation, machine learning algorithms, cancer treatment, drug design, computational biology, digital patient modeling, precision medicine, bioinformatics, oncology, molecular effect prediction, clinical trial optimization, biotech innovation

No funding data available for BioAlg Corp. yet.

BioAlg Corp. Alternatives & Competitors

BioAlg Corp. vs

Cancer drug development comes of age.

Post-IPO Equity
190 employees
Biopharma, Biotechnology
BioAlg Corp. vs
Ancora.ai
Ancora.ai Switzerland

Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to c...

Grant
9 employees
AI, Big Data
BioAlg Corp. vs

AI-powered therapeutics for treatment-resistant cancer

Seed
7 employees
Biotechnology, Pharmaceutical

FAQ About BioAlg Corp.

AI & ML in Cancer Biology
BioAlg Corp. was founded in 2017.
BioAlg Corp. is headquartered in Walnut, United States.
BioAlg Corp. operates in Biotechnology, Pharmaceutical and SaaS. Its work centres on AI-driven platform, clinical trials simulation, machine learning algorithms and cancer treatment.
BioAlg Corp. has approximately 1 employees.
Top alternatives and competitors to BioAlg Corp. include Day One Biopharmaceuticals, Ancora.ai, Synamics Therapeutics, Lantern Pharma Inc. (Nasdaq: LTRN), SyntheticGestalt. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioAlg Corp. and Day One Biopharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioAlg Corp., https://bouncewatch.com/company/bioalg-corp, updated 11 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes